Hyseq buys Variagenics
This article was originally published in The Gray Sheet
Cambridge, Massachusetts pharmacogenomics firm's cancer diagnostics program is a key driver of $55.9 mil. stock purchase. Merged firm will be located at current Hyseq headquarters in Sunnyvale, California. Cash resulting from the deal is expected to fund operations through December 2004...
You may also be interested in...
Pharma will oppose a patent pool, but the world still needs a way to guarantee fair access to COVID-19 vaccines.
Sanofi Pasteur head David Loew has been at the heart of the company's bids to develop vaccines for COVID-19 but has decided to accept a different challenge instead and take the helm at Ipsen.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.